13D Filing: Eses Holdings (fze) and Adamis Pharmaceuticals Corp (ADMP)

Page 2 of 9 – SEC Filing

SCHEDULE 13D
CUSIP No. 00547W208 Page 2 of 9
1. Names of Reporting Persons.
I.R.S.  Identification Nos. of above persons (entities only).
Eses Holdings (FZE)
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨
(b) ¨
3. SEC Use Only
4. Source of Funds (See Instructions)
WC
5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
¨
6. Citizenship or Place of Organization
Sharjah, United Arab Emirates
Number
of Shares
Beneficially
Owned
by Each
Reporting
Person With
7.

Sole Voting Power:

0

8.

Shared Voting Power:

1,635,312 shares

9.

Sole Dispositive Power:

0

10.

Shared Dispositive Power:

1,635,312 shares

11.

Aggregate Amount Beneficially Owned by Each Reporting Person:

 
1,635,312 shares

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares  (See Instructions) ¨

Not applicable.
13.

Percent of Class Represented by Amount in Row (11):

 
5.9%  (See Item 5)

14.

Type of Reporting Person (See Instructions)

CO

Follow Dmk Pharmaceuticals Corp (NASDAQ:DMK)